Indietro
MABTHERA conc perf 100 mg/10ml
Roche Pharma (Schweiz) AG
| Articolo | Carenza | Pharmacode | Prezzo | Cat. di dispensazione | Cat. di rimborso | |
|---|---|---|---|---|---|---|
MABTHERA conc perf 100 mg/10ml 2 amp 10 mlAlloga AG | 1930600 | CHF 518.60 | Cat. A | SL / 10% |
Articoli alternativi senza carenza di approvvigionamento segnalata
| Articolo | Carenza | Pharmacode | Prezzo | Cat. di dispensazione | Cat. di rimborso | Relazione farmaceutica | |
|---|---|---|---|---|---|---|---|
RIXATHON conc perf 100 mg/10ml 2 amp 10 mlSandoz Pharmaceuticals AG | 7479477 | CHF 475.35 | Cat. A | SL / 10% | Equivalente | ||
TRUXIMA conc perf 100 mg/10ml 2 flac 10 mlAvosano Industrie Service AG | 7558018 | CHF 475.35 | Cat. A | SL / 10% | Equivalente | ||
RUXIENCE conc perf 100 mg/10ml flac 10 mlPfizer AG | 1115308 | CHF 237.65 | Cat. A | SL / 10% | Equivalente | ||
RUXIENCE conc perf 100 mg/10ml 2 flac 10 mlPfizer AG | 1148007 | CHF 475.35 | Cat. A | SL / 10% | Equivalente | ||
MABTHERA conc perf 500 mg/50ml amp 50 mlAlloga AG | 1930592 | CHF 1267.65 | Cat. A | SL / 10% | Forma | ||
MABTHERA sous-cutané sol inj 1400 mg/11.7ml flacAlloga AG | 6718655 | CHF 1666.05 | Cat. A | SL / 10% | Forma | ||
RIXATHON conc perf 500 mg/50ml amp 50 mlSandoz Pharmaceuticals AG | 7479483 | CHF 1159.80 | Cat. A | SL / 10% | Forma | ||
TRUXIMA conc perf 500 mg/50ml flac 50 mlAvosano Industrie Service AG | 7558024 | CHF 1159.80 | Cat. A | SL / 10% | Forma | ||
RUXIENCE conc perf 500 mg/50ml flac 50 mlPfizer AG | 1115309 | CHF 1159.80 | Cat. A | SL / 10% | Forma |